Chemoinformaics analysis of (S,Z)-2-Methyl-6-(p-tolyl)hept-2-en-1-ol
Molecular Weight | 218.34 | nRot | 5 |
Heavy Atom Molecular Weight | 196.164 | nRig | 7 |
Exact Molecular Weight | 218.167 | nRing | 1 |
Solubility: LogS | -3.694 | nHRing | 0 |
Solubility: LogP | 3.723 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
nHA | 1 | APOL | 40.5214 |
nHD | 1 | BPOL | 22.0706 |
QED | 0.745 |
Synth | 2.67 |
Natural Product Likeliness | 1.32 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.035 |
Pgp-sub | 0.027 |
HIA | 0.005 |
CACO-2 | -4.399 |
MDCK | 0.0000214 |
BBB | 0.987 |
PPB | 0.930136 |
VDSS | 2.592 |
FU | 0.0796686 |
CYP1A2-inh | 0.804 |
CYP1A2-sub | 0.93 |
CYP2c19-inh | 0.72 |
CYP2c19-sub | 0.758 |
CYP2c9-inh | 0.414 |
CYP2c9-sub | 0.489 |
CYP2d6-inh | 0.499 |
CYP2d6-sub | 0.891 |
CYP3a4-inh | 0.266 |
CYP3a4-sub | 0.543 |
CL | 10.257 |
T12 | 0.773 |
hERG | 0.061 |
Ames | 0.038 |
ROA | 0.03 |
SkinSen | 0.938 |
Carcinogencity | 0.487 |
EI | 0.992 |
Respiratory | 0.21 |
NR-Aromatase | 0.008 |
Antiviral | Yes |
Prediction | 0.838008 |